Full profile
| Also known as | CocoaVia, Epicatechin |
|---|---|
| Best for | Acute cerebral blood flow support · Acute attention support |
| Evidence grade | Grade B — Moderate — several human trials, some mixed results |
| Studied dose range | ~500 mg cocoa flavanols/day (roughly 80 mg epicatechin). |
| Time to effect | Acute — cerebral blood flow and attention effects measured within hours of a single dose. |
| Best form | CocoaVia or an equivalent de-theobrominated, low-theobromine cocoa flavanol extract, to keep the product stimulant-free. |
Evidence, honestly graded
Qualified B. Acute cerebral-blood-flow RCTs (Scientific Reports, 2020) found a single dose improved blood flow and attention measures. But the large chronic COSMOS trial (2023, doi:10.1002/alz.12767) — a multi-year trial in older adults — was null on its primary global-cognition endpoint. We state that plainly: the acute signal is real, the chronic global-cognition claim is not supported by the best available trial.
See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.
Side effects
- Generally well tolerated
- Excellent overall safety profile
Interactions
- No material known interactions at studied doses
Stacks well with
- L-Theanine
What to look for on a label
- Specify a de-theobrominated or low-theobromine extract to keep the stimulant-free positioning honest — regular cocoa extract carries meaningful theobromine.
- Frame as acute blood-flow/attention support, not a chronic global-cognition benefit — the largest chronic trial (COSMOS) was null on that endpoint.
References
- Acute cocoa flavanol cerebral blood flow RCTs, Scientific Reports 2020. Single dose improved cerebral blood flow and attention measures in healthy adults versus placebo. Educational, not a product claim.
- COSMOS 2023 — chronic cocoa flavanol trial, null primary endpoint. Large, multi-year RCT in older adults; null on its primary global-cognition endpoint. doi:10.1002/alz.12767. Stated plainly as the honest limit on the chronic claim.
Primary citations for some entries above are still being compiled; those without a linked identifier are editorial summaries of the wider literature.
Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.
See how Cocoa Flavanols compares on grade, dose, and goal in the Evidence Explorer.
